IDRI Adds Viral Vaccine Development Expertise; Expands Leadership for Vaccine Development

April 14th, 2016|Press Releases|

Seattle, WA | April 14, 2016 FOR IMMEDIATE RELEASE: SEATTLE, April 14, 2016: IDRI (Infectious Disease Research Institute) is expanding its expertise in the field of viral diseases with the addition of Dan Stinchcomb, Ph.D., who has more than [...]

IDRI and Sanofi Pasteur Team with Philanthropy to Develop New Model for Vaccine Development

October 15th, 2015|Press Releases|

Seattle, WA | October 15, 2015 FOR IMMEDIATE RELEASE: Seattle, WA | October 15, 2015 : In an effort to accelerate timelines and decrease development costs of life-saving vaccines, the Infectious Disease Research Institute (IDRI) and Sanofi Pasteur today announce the establishment of [...]

RTC Fellows Join IDRI to Work on HIV Cure Initiative

September 28th, 2015|Press Releases|

Seattle, WA | Sept. 28, 2015 FOR IMMEDIATE RELEASE: SEATTLE, September 28, 2015: As part of the prestigious Merck Fellowship for Global Health, IDRI (Infectious Disease Research Institute) is hosting two Fellows – Todd Kennedy, national account executive, Merck, [...]

IDRI and Wellcome Trust Team for Tuberculosis Vaccine Trial in South Africa

September 17th, 2015|Press Releases|

Seattle, WA | September 17, 2015 FOR IMMEDIATE RELEASE: SEATTLE, September 17, 2015: Today, the Infectious Disease Research Institute (IDRI) and Wellcome Trust announce the start of a Phase 2a trial in South Africa of IDRI’s tuberculosis (TB) vaccine [...]

IDRI’s Tanya Parish Appointed to New Positions

July 21st, 2015|Press Releases|

Seattle, WA | July 21, 2015 FOR IMMEDIATE RELEASE: SEATTLE, July 21, 2015: Tanya Parish, Ph.D., Vice President of Drug Discovery, for IDRI (Infectious Disease Research Institute) has been appointed to two prestigious positions: Editor-in-Chief of the scientific journal [...]

IDRI Announces $4M BARDA Cooperative Agreement to Establish Adjuvant Hub

February 19th, 2015|Press Releases|

Seattle, WA | February 19, 2015 FOR IMMEDIATE RELEASE: SEATTLE, Feb. 19, 2015: The international outbreak of Ebola in 2014 serves as a reminder for the need to be proactive in preparing for the rapid spread of any newly [...]

IDRI Expands Board of Directors, Names New Board Chair

January 8th, 2015|Press Releases|

Seattle, WA | January 8, 2015 FOR IMMEDIATE RELEASE: SEATTLE, January 8, 2015: IDRI (Infectious Disease Research Institute) is expanding its Board of Directors, comprised of international leaders in industry and academia, with the recent addition of Bruce L.A. [...]

IDRI Expands Board of Directors, Adding Vaccine Development Expertise

December 16th, 2014|Press Releases|

Seattle, WA | December 16, 2014 FOR IMMEDIATE RELEASE: SEATTLE, Dec. 16, 2014: A consultant for the international vaccine community who has had a long career in research and development, Michel De Wilde, Ph.D., has joined the IDRI (Infectious [...]

IDRI Announces $11.9M Contract to Develop Thermostable TB Vaccine

November 19th, 2014|Press Releases|

Seattle, WA | November 19, 2014 FOR IMMEDIATE RELEASE: SEATTLE, Nov. 19, 2014: With the goal of developing a thermostable tuberculosis vaccine that is resistant to damage from excessive heat or cold, IDRI (Infectious Disease Research Institute) today announces [...]

IDRI Named Outstanding Global Health Organization by WGHA

August 25th, 2014|Press Releases|

Seattle, WA | August 25, 2014 FOR IMMEDIATE RELEASE: SEATTLE, Aug. 25, 2014: IDRI (Infectious Disease Research Institute) has been named as the recipient of the inaugural Outstanding Global Health Organization award, presented by the Washington Global Health Alliance [...]

Load More